Latest news:
FDA Announces Shift Away from Mandatory Animal Testing – BioReperia Offers a Validated, Human-Relevant Alternative
Read more
Scientific resources

Scientific content

Here you can access posters and webinars produced by BioReperia and our partners.

Webinars

All webinars can be accessed through BioReperia´s YouTube channel.

Advancing Prostate Cancer Targeted Therapy: Breaktroughs Using Zebrafish Tumor Xenograft Models.

co-hosted by Mount Sinai

Joining us was Sujit Nair, PhD (Assistant Professor and Director of GU immunotherapy research at the Icahn School of Medicine) and Lasse Jensen, PhD (Senior Associate Professor at Linköping University and CTO at BioReperia) as they discuss their research and answer questions on this topic of using zebrafish as a rapid in vivo model system.

Advancing Human Disease Research with Zebrafish Models: From Tank to Bedside.

co-hosted by In Vivo BioSystems

Joining us was Joseph Bruckner, PhD (Director of Biology at InVivo Biosystems, Oregon) and Gabriela Vazquez Rodriguez , PhD (Project Manager at BioReperia, Sweden) as they discuss their research and answer questions on this topic of using zebrafish as a rapid in vivo model system.

Zebrafish Models for Breast Cancer Research: An Immunology Focus.

Joining us were Rispah Torrorey-Sawe, PhD (Senior Lecturer at Moi University, Kenya), and Gabriela Vazquez Rodriguez, PhD (Project Manager at BioReperia), who shared their research and answered questions on aggressive triple-negative breast cancer, with a focus on the higher prevalence of this subtype among Black women.

Extracellular Vesicles in Cancer Research: New opportunities by using Zebrafish tumor xenografts

Joining us were Associate Professor Linda Bojmar, PhD (Linköping University, Sweden), and Associate Professor Lasse Jensen, PhD (Linköping University, Sweden, and CTO & Co-founder of BioReperia), who shared their research and answered questions on this topic.

In vivo zebrafish-based metastatic model for analyzing the effect of novel anti-cancer strategies.

Joining us was associate professor Lasse Jensen, PhD (Linköping University, Sweden and CTO & Co-founder at BioReperia) as they discuss their research and answer questions on this topic.

Zebrafish tumor xenograft models: a prognostic approach to epithelial ovarian cancer.

join Associate Professor (LiU) and BioReperia’s CTO and co-founder Lasse Jensen as we discuss the use of zebrafish embryos and tumor xenografts in ovarian cancer research.

This website uses cookies

We use essential cookies to make our website work. With your consent, we also use non-essential cookies to improve the user experience and analyze website traffic. You can change your cookie settings at any time by clicking on Cookie settings..

Which cookies do you want to accept?

This website uses cookies

We use different types of cookies to optimize your experience on our website. Click on the categories below to learn more about their purposes. You can choose which types of cookies to allow and can change your settings at any time. Remember that disabling cookies may affect your experience on the website.

Which cookies do you want to accept?

These cookies are essential for the proper functioning of the website and cannot be disabled.

These cookies collect information about how you use our website. All of the data is anonymized and cannot be used to identify you.

Read more about Google's privacy policy and terms of use